BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16417654)

  • 1. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.
    Lee S; Mohsin SK; Mao S; Hilsenbeck SG; Medina D; Allred DC
    Breast Cancer Res; 2006; 8(1):R6. PubMed ID: 16417654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.
    Lee S; Medina D; Tsimelzon A; Mohsin SK; Mao S; Wu Y; Allred DC
    Am J Pathol; 2007 Jul; 171(1):252-62. PubMed ID: 17591970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cell identity in hyperplastic precursors of breast cancer.
    Coradini D; Boracchi P; Oriana S; Biganzoli E; Ambrogi F
    Chin J Cancer; 2015 Mar; 34(3):121-9. PubMed ID: 25962646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.
    Yang XR; Figueroa JD; Hewitt SM; Falk RT; Pfeiffer RM; Lissowska J; Peplonska B; Brinton LA; Garcia-Closas M; Sherman ME
    Breast Cancer Res Treat; 2013 Feb; 137(3):837-47. PubMed ID: 23271326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland.
    Russo J; Ao X; Grill C; Russo IH
    Breast Cancer Res Treat; 1999 Feb; 53(3):217-27. PubMed ID: 10369068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
    Guix M; Granja Nde M; Meszoely I; Adkins TB; Wieman BM; Frierson KE; Sanchez V; Sanders ME; Grau AM; Mayer IA; Pestano G; Shyr Y; Muthuswamy S; Calvo B; Krontiras H; Krop IE; Kelley MC; Arteaga CL
    J Clin Oncol; 2008 Feb; 26(6):897-906. PubMed ID: 18180460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of c-jun protein in proliferation and apoptosis of the endometrium throughout the menstrual cycle.
    Udou T; Hachisuga T; Tsujioka H; Kawarabayashi T
    Gynecol Obstet Invest; 2004; 57(3):121-6. PubMed ID: 14691341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
    Salagame U; Banks E; O'Connell DL; Egger S; Canfell K
    PLoS One; 2018; 13(11):e0205034. PubMed ID: 30403669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
    Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
    Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer.
    Dowsett M; Dixon JM; Horgan K; Salter J; Hills M; Harvey E
    Clin Cancer Res; 2000 Jun; 6(6):2260-7. PubMed ID: 10873076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
    Lin CS; Chang SC; Ou LH; Chen CM; Hsieh SS; Chung YP; King KL; Lin SL; Wei YH
    Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of steroid hormone receptors, proliferation and apoptotic markers in primate endometrium.
    Narkar M; Kholkute S; Chitlange S; Nandedkar T
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):107-13. PubMed ID: 16406267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF expression is associated with negative estrogen receptor status in patients with breast cancer.
    Fuckar D; Dekanić A; Stifter S; Mustać E; Krstulja M; Dobrila F; Jonjić N
    Int J Surg Pathol; 2006 Jan; 14(1):49-55. PubMed ID: 16501835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line.
    Barrón-González A; Castro Romero I
    Biochem Cell Biol; 2004 Apr; 82(2):335-42. PubMed ID: 15060629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.